CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
CureVac EPS Diluted (Quarterly) : 1.414 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.414 |
| June 30, 2025 | -0.30 |
| March 31, 2025 | -0.2435 |
| December 31, 2024 | -0.1558 |
| September 30, 2024 | 1.649 |
| June 30, 2024 | -0.3482 |
| March 31, 2024 | -0.3414 |
| December 31, 2023 | -0.416 |
| September 30, 2023 | -0.2365 |
| June 30, 2023 | -0.3277 |
| March 31, 2023 | -0.2914 |
| December 31, 2022 | -0.6737 |
| September 30, 2022 | -0.2527 |
| June 30, 2022 | -0.3269 |
| March 31, 2022 | -0.0905 |
| December 31, 2021 | -0.0118 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.9076 |
| June 30, 2021 | -0.9844 |
| March 31, 2021 | -0.744 |
| December 31, 2020 | -0.3841 |
| September 30, 2020 | -0.2313 |
| June 30, 2020 | -0.0606 |
| March 31, 2020 | -0.1406 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.1294 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PAION AG | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alkermes Plc | -0.40 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 319.28M |
| Revenue (Quarterly) | 63.26M |
| Total Expenses (Quarterly) | -256.02M |
| Enterprise Value | 601.60M |
| Gross Profit Margin (Quarterly) | 91.57% |
| Earnings Yield | 15.33% |
| Normalized Earnings Yield | 15.43 |